Ultrasensitive Peptide-Based Electrochemical Biosensor for Universal Diagnostic of Dengue

Dengue is a neglected disease mainly affecting tropical and subtropical countries. The diagnosis of dengue fever is still a problem since most of it is made from whole or recombinant DENV proteins, which present cross-reactions with other members of the Flavivirus family. Therefore, there is still a huge demand for new diagnostic methods that provide rapid, low-cost, easy-to-use confirmation. Thus, in this work, we developed an affordable electrochemical biosensor for rapidly detecting immunoglobulin G (IgG) serological antibodies in the sera of DENV-infected patients. Materials and methods: An identified linear B-cell epitope (DENV/18) specific for DENV 1-4 serotypes recognized by IgG in patient sera was selected as a target molecule after a microarray of peptides using the Spot-synthesis methodology. After chemical synthesis, the DENV/18-peptide was immobilized on the surface of the working electrode of a commercially available screen-printed gold electrode (SPGE). The capture of DENV-specific IgG allowed the formation of an immunocomplex that was measured by cyclic voltammetry (CV) and differential pulse voltammetry (DPV) using a potassium ferri-iron cyanide K+ ([Fe(CN)6]3-/4-) electrochemical probe. Results: An evaluation of the performance of the biosensor showed a detection limit of 100 µg mL-1 for the synthetic peptides (DENV/18) and 0.002 µg mL−1 for human serum, with a sensitivity of 7.21 µA in CV and 8.79 µA in DPV. The differentiation of infected and uninfected individuals was possible even at a high dilution factor that reduced the required sample volumes to a few microliters. Conclusion: The final device proved suitable for diagnosing DENV by analyzing real serum samples, and the results showed good agreement with molecular biology diagnostics. The flexibility to conjugate other antigenic peptides to SPEs suggests that this technology could be rapidly adapted to diagnose other pathogens.